Our Journey in Vaccines
Sanofi has been a leader in vaccines for more than 100 years. The combination of our innovative vaccines and global reach means that many diseases
do not hold the power they once did. Our determination to improve public health motivates
us to develop new vaccines to address still unmet medical needs.
Fueled by new data and digital technologies, our science and manufacturing have the
potential to transform the practice of medicine for millions of people around the
world. And when we discover the extraordinary, we’re already planning where to go
next. Because everyone deserves a chance to plan for their future, to dream big.
Our vaccines are available in ~150 countries
500 million people vaccinated annually with our vaccines, worldwide
2.5 million vaccine doses supplied, every day
€500 million invested in vaccines R&D each year
Our Journey in Specialty Care
As the Specialty Care Global Business Unit of Sanofi, our work is focused in the areas
of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
Each day we continue to advance new therapies, demonstrating our commitment to making
a positive impact on the lives of patients around the world.
Specialty Care focuses on developing transformative specialty treatments for debilitating
diseases that are often difficult to diagnose and treat, providing hope to patients
and their families.
We are driven by our patient-focused science led approach and our ambition is to be
the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical
trials and in Sanofi laboratories. This is made possible by the significant expertise
of market access professionals in countries and globally who are passionate about
their mission.
|
